Clinical Trial Update: Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Velphoro's impact on serum phosphate and albumin in peritoneal dialysis patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoalbuminemia in Peritoneal Dialysis
• Peritoneal Dialysis-related Hyperphosphatemia

Drugs mentioned

• VELPHORO (sucroferric oxyhydroxide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Peritoneal Dialysis Complication, Hyperphosphatemia | Phase 4 | Status: COMPLETED | Results posted: 2022-08-31